期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 76, 期 1, 页码 45-65出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-018-2924-7
关键词
Cancer stem cells; Epigenetics; Induced pluripotent stem cells; Organoid culture; Reactive oxygen species; Somatic cell nuclear transfer
资金
- Ministry of Science and Technology [MOST 106-2320-B-037-001-MY3, MOST 106-2320-B-037-028, MOST 106-2314-B-037-017]
- National Health Research Institutes [NHRI-Ex107-10720SI]
- Kaohsiung Medical University [KMU-TP103A04, KMU-TP103G03, KMU-TP104E23, KMU-DT104001]
The ability to control the transition from an undifferentiated stem cell to a specific cell fate is one of the key techniques that are required for the application of interventional technologies to regenerative medicine and the treatment of tumors and metastases and of neurodegenerative diseases. Reprogramming technologies, which include somatic cell nuclear transfer, induced pluripotent stem cells, and the direct reprogramming of specific cell lineages, have the potential to alter cell plasticity in translational medicine for cancer treatment. The characterization of cancer stem cells (CSCs), the identification of oncogene and tumor suppressor genes for CSCs, and the epigenetic study of CSCs and their microenvironments are important topics. This review summarizes the application of cell reprogramming technologies to cancer modeling and treatment and discusses possible obstacles, such as genetic and epigenetic alterations in cancer cells, as well as the strategies that can be used to overcome these obstacles to cancer research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据